Tomoya Tsuchihashi

Zymosan-adjuvanted intranasal norovirus virus-like particle vaccine induces antiviral mucosal immune responses in infant mice.

Infants require repeated immunizations of injectable-type vaccines against different pathogens because their immune systems are weaker than those of adults. However, these injectable vaccines cause physical and psychological discomfort. Therefore, there is an urgent need to develop pain-free mucosal vaccines that are o...